MétaCan
Menu
Back to cohort
Record W2915544780 · doi:10.3747/co.26.4116

Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer

2019· article· en· W2915544780 on OpenAlexafffundvenueabout
Scott A. Laurie, Shantanu Banerji, Normand Blais, Stephanie Yasmin Brule, Parneet Cheema, Patrick Cheung, Nathalie Daaboul, Desirée Hao, Vera Hirsh, Rosalyn A. Juergens, Janessa Laskin, Natasha B. Leighl, Robert M. MacRae, Garth Nicholas, David Roberge, J. Rothenstein, David J. Stewart, Ming‐Sound Tsao

Bibliographic record

VenueCurrent Oncology · 2019
Typearticle
Languageen
FieldMedicine
TopicLung Cancer Treatments and Mutations
Canadian institutionsUniversity of CalgaryCentre Hospitalier de l’Université de MontréalAlberta Cancer FoundationMcGill University Health CentreBC Cancer AgencyPrincess Margaret Cancer CentreOttawa HospitalUniversity of ManitobaCancerCare ManitobaUniversity of Ottawa
FundersPfizer CanadaBristol-Myers Squibb CanadaEMD SeronoSiemens HealthineersAstraZeneca CanadaVarian Medical SystemsSanofiAmgenPfizerCelgeneHealth ResearchBristol-Myers SquibbEli Lilly and CompanyAstraZenecaMerck CanadaAccuray
KeywordsMedicineClinical trialClinical PracticeBest practiceMedical physicsMEDLINEIntensive care medicineConsensus conferenceLung cancerQuality of life (healthcare)Family medicineOncologyPathologyNursingInternal medicine

Abstract

fetched live from OpenAlex

Background: Little evidence has been generated for how best to manage patients with non-small-cell lung cancer (nsclc) presenting with rarer clinical scenarios, including oligometastases, oligoprogression, and pseudoprogression. In each of those scenarios, oncologists have to consider how best to balance efficacy with quality of life, while maximizing the duration of each line of therapy and ensuring that patients are still eligible for later options, including clinical trial enrolment. Methods: An expert panel was convened to define the clinical questions. Using case-based presentations, consensus practice recommendations for each clinical scenario were generated through focused, evidence-based discussions. Results: Treatment strategies and best-practice or consensus recommendations are presented, with areas of consensus and areas of uncertainty identified. Conclusions: In each situation, treatment has to be tailored to suit the individual patient, but with the intent of extending and maximizing the use of each line of treatment, while keeping treatment options in reserve for later lines of therapy. Patient participation in clinical trials examining these issues should be encouraged.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.048
metaresearch head score (Gemma)0.097
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.716
Threshold uncertainty score0.565

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0480.097
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0040.004
Science and technology studies0.0060.005
Scholarly communication0.0050.003
Open science0.0050.006
Research integrity0.0120.011
Insufficient payload (model declined to judge)0.0090.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.403
Teacher spread0.371 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations49
Published2019
Admission routes4
Has abstractyes

Explore more

Same venueCurrent OncologySame topicLung Cancer Treatments and MutationsFrench-language works237,207